Now I would think, and I would be pleased to have your comments on this, that there is an argument to be made on the manufacturing side where a compounder is making a significant quantity of a compounded product to then be sold, as opposed to the pharmaceutical side where a pharmacist is compounding one product for one prescription.
Blunt discusses the need for oversight in compounding pharmacies versus traditional manufacturing.
Share
More from Roy Blunt
We need to move forward with the clarifications that are so obviously needed.
...Indian Tribes are political, sovereign entities to which the Federal Government owes a trust responsibility.
Yesterday, October the 16th, the Corps announced that the Missouri River flood was officially over.
Please continue this commitment and provide timely investments public health and research programs at the CDC and in the NIH.
Other voices in this conversation
